ERCC1
DNA excision repair protein ERCC-1
Also known as: ERCC1_HUMAN, RAD10
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P07992
- Gene
- ERCC1
- Ensembl
- ENSG00000012061
- Chromosome
- 19
- Canonical length
- 297 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The product of this gene functions in the nucleotide excision repair pathway, and is required for the repair of DNA lesions such as those induced by UV light or formed by electrophilic compounds including cisplatin. The encoded protein forms a heterodimer with the XPF endonuclease (also known as ERCC4), and the heterodimeric endonuclease catalyzes the 5' incision in the process of excising the DNA lesion. The heterodimeric endonuclease is also involved in recombinational DNA repair and in the repair of inter-strand crosslinks. Mutations in this gene result in cerebrooculofacioskeletal syndrome, and polymorphisms that alter expression of this gene may play a role in carcinogenesis. Multiple transcript variants encoding different isoforms have been found for this gene. The last exon of this gene overlaps with the CD3e molecule, epsilon associated protein gene on the opposite strand. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>P07992|ERCC1
1 MDPGKDKEGV PQPSGPPARK KFVIPLDEDE VPPGVAKPLF RSTQSLPTVD TSAQAAPQTY
61 AEYAISQPLE GAGATCPTGS EPLAGETPNQ ALKPGAKSNS IIVSPRQRGN PVLKFVRNVP
121 WEFGDVIPDY VLGQSTCALF LSLRYHNLHP DYIHGRLQSL GKNFALRVLL VQVDVKDPQQ
181 ALKELAKMCI LADCTLILAW SPEEAGRYLE TYKAYEQKPA DLLMEKLEQD FVSRVTECLT
241 TVKSVNKTDS QTLLTTFGSL EQLIAASRED LALCPGLGPQ KARRLFDVLH EPFLKVPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERCC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 103 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 103 nTPM
- skeletal muscle: 81 nTPM
- tongue: 77 nTPM
- choroid plexus: 74 nTPM
- salivary gland: 67 nTPM
- blood vessel: 58 nTPM
Single-cell type
- epicardial cells: 5,322 nCPM
- salivary myoepithelial cells: 1,326 nCPM
- mast cells: 748 nCPM
- salivary acinar cells: 734 nCPM
- salivary basal cells: 690 nCPM
- endometrial stromal cells: 646 nCPM
Immune cell
- plasmacytoid DC: 317 nTPM
- intermediate monocyte: 143 nTPM
- myeloid DC: 135 nTPM
- classical monocyte: 132 nTPM
- non-classical monocyte: 108 nTPM
- total PBMC: 90 nTPM
Brain region
- choroid plexus: 64 nTPM
- cerebral cortex: 54 nTPM
- medulla oblongata: 52 nTPM
- cerebellum: 49 nTPM
- hypothalamus: 48 nTPM
- pons: 48 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ERCC1.
Disease | AllUniProt
Conditions ERCC1 is implicated in, by any mechanism.
- Cerebro-oculo-facio-skeletal syndrome 4 (COFS4) MIM:610758
Disease | GeneticClinVar
15 pathogenic / likely-pathogenic of 205 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cerebrooculofacioskeletal syndrome 4
- Cockayne syndrome
- Global proximal tubulopathy
- Failure to thrive
- Cholestatic liver disease
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.3
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.66
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- determination of adult lifespan
- DNA repair
- double-strand break repair via nonhomologous end joining
- insulin-like growth factor receptor signaling pathway
- interstrand cross-link repair
- isotype switching
- male gonad development
- mitotic recombination
- multicellular organism growth
- negative regulation of protection from non-homologous end joining at telomere
- negative regulation of telomere maintenance
- nucleotide-excision repair
- oogenesis
- positive regulation of t-circle formation
- positive regulation of transcription initiation by RNA polymerase II
- post-embryonic hemopoiesis
- pyrimidine dimer repair by nucleotide-excision repair
- replicative senescence
- response to oxidative stress
- response to X-ray
- spermatogenesis
- syncytium formation
- t-circle formation
- telomeric DNA-containing double minutes formation
- UV protection
- UV-damage excision repair
Molecular functions
- damaged DNA binding
- promoter-specific chromatin binding
- single-stranded DNA binding
- TFIID-class transcription factor complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RuvA domain 2-like
- Restriction endonuclease type II-like
- Helix-hairpin-helix domain
- ERCC1/RAD10/SWI10 family
- ERCC1-like, central domain
- Binding domain of DNA repair protein Ercc1 (rad10/Swi10)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ERCC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERCC1 as an antibody target. Whether an autoantibody or antibody against ERCC1 could matter depends on whether native ERCC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERCC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ERCC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...